Clinical trial
Naltrexone & SSRI in Alcoholics With Depression/PTSD
NCT00338962 · Yale University, Other · Completed
Key facts
| NCT number | NCT00338962 |
|---|---|
| Title | Naltrexone & SSRI in Alcoholics With Depression/PTSD |
| Official title | Naltrexone & SSRI in Alcoholics With Depression/PTSD |
| Lead sponsor | Yale University, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Alcoholism, Depression, PTSD |
| Intervention type | Drug |
| Interventions | paroxetine, desipramine, Naltrexone, Placebo |
| Enrollment | 88 |
| Start date | Oct 1, 2001 |
| Primary completion | Jul 1, 2015 |
| Completion | Jul 1, 2015 |
| First posted | Jun 20, 2006 |
| Last update posted | Feb 5, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: